ANRO logo

Alto Neuroscience, Inc. (ANRO)

Profile

Full Name

Alto Neuroscience, Inc.

Ticker

NYSE: ANRO

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 2, 2024

Indexes

Not included

Website

https://www.altoneuroscience.com

Employees

76

Key Details

Price

$11.00(-1.61%)

Market Cap

$340.00M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$2.50(-84.91% YoY)

PE Ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.00
    ANRO price is $11.00

    30-Day Relative Volume

    0.12
    ANRO 30-day relative volume is 0.12

    Price Performance

    Price Most Recent Change

    -1.61%
    ANRO price was down -1.61% on Oct 24, 2025

    Price YTD Change

    +160.05%
    ANRO price is up +160.05% since January 1st

    Price 1-Year Change

    +151.72%
    ANRO price is up +151.72% year-on-year

    Price 3-Year Change

    -
    ANRO price 3-year change is unknown

    Price Range

    Price All-Time High

    $24.00
    ANRO price is currently -54.17% below its historical high of $24.00

    Price 3-Year Low

    $1.60
    ANRO price is currently +587.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $340.00M
    ANRO market cap is $340.00 million

    Market Cap 3-Year Change

    -
    ANRO market cap 3-year change is unknown

    Market Cap All-Time High

    $583.81M
    ANRO market cap is currently -41.76% below its historical high of $583.81 million

    Market Cap Sector Percentile

    56.47%
    ANRO market cap is higher than 56.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +14.61%
    ANRO shares outstanding is up +14.61% year-on-year

    Shares Outstanding 3-Year Change

    -
    ANRO shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.00
    ANRO beta is 1.00

    200-day SMA

    $3.43
    ANRO price is currently +220.62% above its 200-day simple moving average

    50-day SMA

    $5.02
    ANRO price is currently +119.27% above its 50-day simple moving average

    14-Day RSI

    76.16
    ANRO 14-day relative strength index is 76.16

    Volume

    0.12
    ANRO 30-day relative volume is 0.12

    ATR

    $1.00
    ANRO average true range is $1.00

    10-day Historical Volatility

    410.37%
    ANRO 10-day historical volatility is 410.37%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ANRO annual revenue is $0.00

    Revenue Analysts Estimate

    -
    ANRO annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    ANRO annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.78%
    ANRO annual revenue is higher than 28.78% of companies in Healthcare sector

    EPS

    EPS

    -$2.50
    ANRO annual earnings per share is -$2.50

    EPS Analysts Estimate

    -$2.46
    ANRO annual earnings per share is currently -1.69% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -84.91%
    ANRO annual earnings per share is down -84.91% year-on-year

    EPS Sector Percentile

    34.6%
    ANRO annual earnings per share is higher than 34.6% of companies in Healthcare sector

    Profit

    Gross Profit

    -$502.00K
    ANRO annual gross profit is -$502.00 thousand

    Gross Margin

    -
    ANRO annual gross profit margin value is unknown

    Operating Profit

    -$68.61M
    ANRO annual operating income is -$68.61 million

    Operating Margin

    -
    ANRO annual operating profit margin value is unknown

    Net Income

    -$61.43M
    ANRO annual net profit is -$61.43 million

    Net Margin

    -
    ANRO annual net profit margin value is unknown

    Expenses

    Total Expenses

    $68.61M
    ANRO annual total expenses is $68.61 million

    Operating Expenses

    $68.61M
    ANRO annual total operating expenses is $68.61 million

    Cost Of Goods Sold

    $502.00K
    ANRO annual cost of goods sold is $502.00 thousand

    Selling, General & Administrative Expenses

    $21.61M
    ANRO annual SG&A is $21.61 million

    Depreciation & Amortization

    $502.00K
    ANRO annual D&A is $502.00 thousand

    Interest Expense

    $0.00
    ANRO annual interest expense is $0.00

    Income Tax

    $0.00
    ANRO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$60.06M
    ANRO annual earnings before interest & taxes is -$60.06 million

    EBITDA

    -$59.55M
    ANRO annual EBITDA is -$59.55 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $177.54M
    ANRO annual total assets is $177.54 million

    Non Current Assets

    $8.21M
    ANRO annual long term assets is $8.21 million

    Current Assets

    $169.34M
    ANRO annual total current assets is $169.34 million

    Cash and Cash Equivalents

    $168.23M
    ANRO annual cash & cash equivalents is $168.23 million

    Accounts Receivable

    -
    ANRO annual accounts receivable value is unknown

    Inventory

    $0.00
    ANRO annual inventory is $0.00

    Liabilities

    Total Liabilities

    $26.08M
    ANRO annual total liabilities is $26.08 million

    Long Term Liabilities

    $16.07M
    ANRO annual total long term liabilities is $16.07 million

    Current Liabilities

    $10.01M
    ANRO annual current liabilities is $10.01 million

    Accounts Payable

    $1.58M
    ANRO annual accounts payable is $1.58 million

    Debt

    Total Debt

    $16.94M
    ANRO annual total debt is $16.94 million

    Total Debt 1-Year Change

    -88.81%
    ANRO annual total debt is down -88.81% year-on-year

    Long Term Debt

    $16.07M
    ANRO annual long term debt is $16.07 million

    Short Term Debt

    $870.00K
    ANRO annual short term debt is $870.00 thousand

    Equity & Capital

    Shareholders Equity

    $151.46M
    ANRO annual stockholders equity is $151.46 million

    Book Value

    $151.46M
    ANRO annual book value is $151.46 million

    Retained Earnings

    -$138.40M
    ANRO annual retained earnings is -$138.40 million

    Working Capital

    $159.33M
    ANRO annual working capital is $159.33 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$47.42M
    ANRO annual cash from operations is -$47.42 million

    Cash From Operations 1-Year Change

    -41.78%
    ANRO annual cash from operations is down -41.78% year-on-year

    Cash From Investing

    -$2.08M
    ANRO annual cash from investing is -$2.08 million

    Cash From Investing 1-Year Change

    -341.49%
    ANRO annual cash from investing is down -341.49% year-on-year

    Cash From Financing

    $135.69M
    ANRO annual cash from financing is $135.69 million

    Cash From Financing 1-Year Change

    +99.16%
    ANRO annual cash from financing is up +99.16% year-on-year

    CAPEX

    CAPEX

    $2.08M
    ANRO annual capital expenditures is $2.08 million

    CAPEX 1-Year Change

    +341.49%
    ANRO annual capital expenditures is up +341.49% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$49.50M
    ANRO annual free cash flow is -$49.50 million

    Free Cash Flow 1-Year Change

    -45.94%
    ANRO annual free cash flow is down -45.94% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    ANRO annual gross profit margin value is unknown

    Operating Margin

    -
    ANRO annual operating profit margin value is unknown

    Net Margin

    -
    ANRO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -46.51%
    ANRO annual return on assets is -46.51%

    ROE

    -153.99%
    ANRO annual return on equity is -153.99%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ANRO price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ANRO price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    2.75
    ANRO price to book ratio is 2.75

    PB Ratio Sector Percentile

    59.68%
    ANRO price to book ratio is higher than 59.68% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    ANRO price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    ANRO price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $219.72M
    ANRO enterprise value is $219.72 million

    Enterprise Value Sector Percentile

    54.2%
    ANRO enterprise value is higher than 54.2% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.16
    ANRO EV/EBITDA is -3.16

    EV/EBITDA Sector Percentile

    32.97%
    ANRO EV/EBITDA is higher than 32.97% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    16.92
    ANRO annual current ratio is 16.92

    Quick Ratio

    16.92
    ANRO annual quick ratio is 16.92

    Leverage

    Debt To Equity

    0.11
    ANRO annual debt to equity ratio is 0.11

    Interest Coverage Ratio

    -
    ANRO annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    ANRO piotroski f-score value is unknown

    Altman Z-Score

    6.69
    ANRO altman z-score is 6.69

    Analyst ratings

    Recent major analysts updates

    Oct 24, 25 HC Wainwright & Co.
    Buy
    Oct 20, 25 Baird
    Outperform
    Sep 29, 25 Chardan Capital
    Buy
    Aug 18, 25 HC Wainwright & Co.
    Buy
    Jun 26, 25 HC Wainwright & Co.
    Buy
    May 15, 25 Wedbush
    Neutral
    Apr 7, 25 HC Wainwright & Co.
    Buy
    Dec 16, 24 Jones Trading
    Buy
    Nov 13, 24 Stifel
    Buy
    Oct 23, 24 Wedbush
    Neutral

    Institutional Ownership

    Screeners with ANRO included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Healthcare sector
    All stocks
    Stocks above analysts price target
    High Altman Z score stocks
    Stocks with high RSI
    • What is the ticker symbol for Alto Neuroscience, Inc.?
    • Does Alto Neuroscience, Inc. pay dividends?
    • What sector is Alto Neuroscience, Inc. in?
    • What industry is Alto Neuroscience, Inc. in?
    • What country is Alto Neuroscience, Inc. based in?
    • When did Alto Neuroscience, Inc. go public?
    • Is Alto Neuroscience, Inc. in the S&P 500?
    • Is Alto Neuroscience, Inc. in the NASDAQ 100?
    • Is Alto Neuroscience, Inc. in the Dow Jones?
    • When was Alto Neuroscience, Inc.'s last earnings report?
    • When does Alto Neuroscience, Inc. report earnings?

    What is the ticker symbol for Alto Neuroscience, Inc.?

    The ticker symbol for Alto Neuroscience, Inc. is NYSE:ANRO

    Does Alto Neuroscience, Inc. pay dividends?

    No, Alto Neuroscience, Inc. does not pay dividends

    What sector is Alto Neuroscience, Inc. in?

    Alto Neuroscience, Inc. is in the Healthcare sector

    What industry is Alto Neuroscience, Inc. in?

    Alto Neuroscience, Inc. is in the Biotechnology industry

    What country is Alto Neuroscience, Inc. based in?

    Alto Neuroscience, Inc. is headquartered in United States

    When did Alto Neuroscience, Inc. go public?

    Alto Neuroscience, Inc.'s initial public offering (IPO) was on February 2, 2024

    Is Alto Neuroscience, Inc. in the S&P 500?

    No, Alto Neuroscience, Inc. is not included in the S&P 500 index

    Is Alto Neuroscience, Inc. in the NASDAQ 100?

    No, Alto Neuroscience, Inc. is not included in the NASDAQ 100 index

    Is Alto Neuroscience, Inc. in the Dow Jones?

    No, Alto Neuroscience, Inc. is not included in the Dow Jones index

    When was Alto Neuroscience, Inc.'s last earnings report?

    Alto Neuroscience, Inc.'s most recent earnings report was on August 13, 2025

    When does Alto Neuroscience, Inc. report earnings?

    The next expected earnings date for Alto Neuroscience, Inc. is November 14, 2025
    On this page